Tags

Type your tag names separated by a space and hit enter

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
Lancet. 2021 07 17; 398(10296):207-209.Lct

Authors+Show Affiliations

Francis Crick Institute, London NW1 1AT, UK; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.University College London, London, UK.University College London, London, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK.Francis Crick Institute, London NW1 1AT, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre, London, UK; NIHR UCLH Clinical Research Facility, London, UK; University College London, London, UK.Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.Francis Crick Institute, London NW1 1AT, UK; University College London, London, UK.Francis Crick Institute, London NW1 1AT, UK. Electronic address: david.bauer@crick.ac.uk.

Pub Type(s)

Letter
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

34197809

Citation

Wall, Emma C., et al. "AZD1222-induced Neutralising Antibody Activity Against SARS-CoV-2 Delta VOC." Lancet (London, England), vol. 398, no. 10296, 2021, pp. 207-209.
Wall EC, Wu M, Harvey R, et al. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021;398(10296):207-209.
Wall, E. C., Wu, M., Harvey, R., Kelly, G., Warchal, S., Sawyer, C., Daniels, R., Adams, L., Hobson, P., Hatipoglu, E., Ngai, Y., Hussain, S., Ambrose, K., Hindmarsh, S., Beale, R., Riddell, A., Gamblin, S., Howell, M., Kassiotis, G., ... Bauer, D. L. (2021). AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet (London, England), 398(10296), 207-209. https://doi.org/10.1016/S0140-6736(21)01462-8
Wall EC, et al. AZD1222-induced Neutralising Antibody Activity Against SARS-CoV-2 Delta VOC. Lancet. 2021 07 17;398(10296):207-209. PubMed PMID: 34197809.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. AU - Wall,Emma C, AU - Wu,Mary, AU - Harvey,Ruth, AU - Kelly,Gavin, AU - Warchal,Scott, AU - Sawyer,Chelsea, AU - Daniels,Rodney, AU - Adams,Lorin, AU - Hobson,Philip, AU - Hatipoglu,Emine, AU - Ngai,Yenting, AU - Hussain,Saira, AU - Ambrose,Karen, AU - Hindmarsh,Steve, AU - Beale,Rupert, AU - Riddell,Andrew, AU - Gamblin,Steve, AU - Howell,Michael, AU - Kassiotis,George, AU - Libri,Vincenzo, AU - Williams,Bryan, AU - Swanton,Charles, AU - Gandhi,Sonia, AU - Bauer,David Lv, Y1 - 2021/06/28/ PY - 2021/06/14/received PY - 2021/06/24/revised PY - 2021/06/25/accepted PY - 2021/7/2/pubmed PY - 2021/7/31/medline PY - 2021/7/1/entrez SP - 207 EP - 209 JF - Lancet (London, England) JO - Lancet VL - 398 IS - 10296 SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/34197809/AZD1222-induced_neutralising_antibody_activity_against_SARS-CoV-2_Delta_VOC. L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(21)01462-8 DB - PRIME DP - Unbound Medicine ER -